Dec 23, 2025 05:30PM
Nov 4, 2025 05:23PM
Sep 10, 2025 10:30AM
May 7, 2025 04:30PM
Feb 24, 2025 04:30PM
Nov 12, 2024 04:05PM
Nov 8, 2024 06:11AM Travere Therapeutics (TVTX) Prices 7.81M Share Offering at $16/sh
Nov 7, 2024 09:05PM
Nov 7, 2024 04:02PM
Nov 7, 2024 04:01PM
Nov 4, 2024 04:30PM
May 8, 2024 04:30PM
Jun 1, 2023 04:30PM
Mar 3, 2023 04:05PM Travere Therapeutics Announces Completion of Public Offering of Common Stock and Pre-Funded Warrants and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Mar 3, 2023 04:05PM
Mar 1, 2023 05:54AM
Feb 28, 2023 10:36PM
Feb 28, 2023 10:36PM
Feb 27, 2023 04:01PM
Feb 27, 2023 04:01PM
Feb 27, 2023 04:01PM Travere Therapeutics Announces Proposed Public Offering of Common Stock
Nov 9, 2022 04:30PM
Nov 9, 2022 04:30PM
Jun 2, 2022 04:30PM
Jun 2, 2022 04:30PM
Mar 9, 2022 04:49AM
Mar 8, 2022 09:00PM
Mar 8, 2022 09:00PM Travere Prices Upsized $275 Million Convertible Senior Notes Offering
Mar 8, 2022 07:01AM
Mar 8, 2022 07:00AM
Mar 8, 2022 07:00AM
Nov 11, 2021 04:30PM
Nov 11, 2021 04:30PM
May 27, 2021 04:30PM
May 27, 2021 04:30PM Travere Therapeutics to Present at Upcoming Investor Conferences
Feb 17, 2021 04:05PM
Feb 17, 2021 04:05PM
Feb 12, 2021 06:05AM
Feb 11, 2021 10:03PM
Feb 11, 2021 10:03PM
Feb 10, 2021 04:01PM
Feb 10, 2021 04:01PM Travere Therapeutics Announces Proposed Public Offering of Common Stock
Feb 10, 2021 04:01PM

69,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All